nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—SLC5A2—nephron—nephrolithiasis	0.105	0.28	CbGeAlD
Canagliflozin—SLC5A2—urine—nephrolithiasis	0.0842	0.224	CbGeAlD
Canagliflozin—Serum potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0551	0.237	CcSEcCtD
Canagliflozin—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0265	0.114	CcSEcCtD
Canagliflozin—SLC5A2—nephron tubule—nephrolithiasis	0.0227	0.0604	CbGeAlD
Canagliflozin—SLC5A2—renal system—nephrolithiasis	0.0206	0.0549	CbGeAlD
Canagliflozin—SLC5A2—kidney—nephrolithiasis	0.0199	0.0531	CbGeAlD
Canagliflozin—SLC5A2—cortex of kidney—nephrolithiasis	0.0194	0.0517	CbGeAlD
Canagliflozin—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.019	0.0485	CbGpPWpGaD
Canagliflozin—SLC5A1—nephron tubule—nephrolithiasis	0.0172	0.0458	CbGeAlD
Canagliflozin—SLC5A1—renal system—nephrolithiasis	0.0156	0.0416	CbGeAlD
Canagliflozin—SLC5A1—kidney—nephrolithiasis	0.0151	0.0402	CbGeAlD
Canagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0134	0.0341	CbGpPWpGaD
Canagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0134	0.0341	CbGpPWpGaD
Canagliflozin—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.013	0.0559	CcSEcCtD
Canagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0124	0.0317	CbGpPWpGaD
Canagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0124	0.0317	CbGpPWpGaD
Canagliflozin—UGT2B4—Phase II conjugation—SLC26A1—nephrolithiasis	0.0104	0.0265	CbGpPWpGaD
Canagliflozin—UGT1A9—renal system—nephrolithiasis	0.00983	0.0262	CbGeAlD
Canagliflozin—UGT1A9—kidney—nephrolithiasis	0.0095	0.0253	CbGeAlD
Canagliflozin—SLC5A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00897	0.0229	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00897	0.0229	CbGpPWpGaD
Canagliflozin—CYP3A4—urine—nephrolithiasis	0.00882	0.0235	CbGeAlD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00878	0.0224	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00878	0.0224	CbGpPWpGaD
Canagliflozin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00862	0.037	CcSEcCtD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00803	0.0205	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00803	0.0205	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00803	0.0205	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00803	0.0205	CbGpPWpGaD
Canagliflozin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0338	CcSEcCtD
Canagliflozin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.00759	0.0194	CbGpPWpGaD
Canagliflozin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00755	0.0324	CcSEcCtD
Canagliflozin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00723	0.0311	CcSEcCtD
Canagliflozin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00667	0.0287	CcSEcCtD
Canagliflozin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00661	0.0284	CcSEcCtD
Canagliflozin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00661	0.0284	CcSEcCtD
Canagliflozin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0262	CcSEcCtD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00608	0.0155	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00608	0.0155	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00608	0.0155	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00608	0.0155	CbGpPWpGaD
Canagliflozin—UGT2B4—Biological oxidations—SLC26A1—nephrolithiasis	0.00608	0.0155	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00567	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00567	0.0145	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00565	0.0144	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00565	0.0144	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00565	0.0144	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00565	0.0144	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00544	0.0234	CcSEcCtD
Canagliflozin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0228	CcSEcCtD
Canagliflozin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0225	CcSEcCtD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00504	0.0129	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00504	0.0129	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.005	0.0128	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.005	0.0128	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.005	0.0128	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.005	0.0128	CbGpPWpGaD
Canagliflozin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00492	0.0211	CcSEcCtD
Canagliflozin—ABCC2—nephron tubule—nephrolithiasis	0.00467	0.0125	CbGeAlD
Canagliflozin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00463	0.0199	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00458	0.0197	CcSEcCtD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00446	0.0114	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00446	0.0114	CbGpPWpGaD
Canagliflozin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00435	0.0187	CcSEcCtD
Canagliflozin—ABCC2—renal system—nephrolithiasis	0.00425	0.0113	CbGeAlD
Canagliflozin—ABCC2—kidney—nephrolithiasis	0.00411	0.0109	CbGeAlD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00408	0.0104	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00408	0.0104	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00408	0.0104	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00408	0.0104	CbGpPWpGaD
Canagliflozin—ABCC2—cortex of kidney—nephrolithiasis	0.004	0.0107	CbGeAlD
Canagliflozin—UGT1A9—Phase II conjugation—SLC26A1—nephrolithiasis	0.00384	0.00981	CbGpPWpGaD
Canagliflozin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0035	0.015	CcSEcCtD
Canagliflozin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0137	CcSEcCtD
Canagliflozin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00313	0.0135	CcSEcCtD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00309	0.00788	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00309	0.00788	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00309	0.00788	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00309	0.00788	CbGpPWpGaD
Canagliflozin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00307	0.0132	CcSEcCtD
Canagliflozin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00291	0.0125	CcSEcCtD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00287	0.00733	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00287	0.00733	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00287	0.00733	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00287	0.00733	CbGpPWpGaD
Canagliflozin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00281	0.0121	CcSEcCtD
Canagliflozin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00267	0.0115	CcSEcCtD
Canagliflozin—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00256	0.00654	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00256	0.00653	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00256	0.00653	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00256	0.00653	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00256	0.00653	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0025	0.00638	CbGpPWpGaD
Canagliflozin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00246	0.0106	CcSEcCtD
Canagliflozin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00244	0.0105	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00233	0.01	CcSEcCtD
Canagliflozin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00974	CcSEcCtD
Canagliflozin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00969	CcSEcCtD
Canagliflozin—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00225	0.00574	CbGpPWpGaD
Canagliflozin—CYP3A4—renal system—nephrolithiasis	0.00216	0.00575	CbGeAlD
Canagliflozin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00903	CcSEcCtD
Canagliflozin—CYP3A4—kidney—nephrolithiasis	0.00209	0.00556	CbGeAlD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00205	0.00522	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00205	0.00522	CbGpPWpGaD
Canagliflozin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00205	0.0088	CcSEcCtD
Canagliflozin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00867	CcSEcCtD
Canagliflozin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00811	CcSEcCtD
Canagliflozin—Rash—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00773	CcSEcCtD
Canagliflozin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00772	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—GRHPR—nephrolithiasis	0.00178	0.00453	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GRHPR—nephrolithiasis	0.00178	0.00453	CbGpPWpGaD
Canagliflozin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00728	CcSEcCtD
Canagliflozin—ABCB1—nephron tubule—nephrolithiasis	0.00168	0.00448	CbGeAlD
Canagliflozin—SLC5A1—Disease—SLC26A1—nephrolithiasis	0.00161	0.0041	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—SLC26A1—nephrolithiasis	0.00161	0.0041	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AGXT—nephrolithiasis	0.00158	0.00404	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AGXT—nephrolithiasis	0.00158	0.00404	CbGpPWpGaD
Canagliflozin—ABCB1—renal system—nephrolithiasis	0.00153	0.00407	CbGeAlD
Canagliflozin—ABCB1—kidney—nephrolithiasis	0.00148	0.00394	CbGeAlD
Canagliflozin—ABCB1—cortex of kidney—nephrolithiasis	0.00144	0.00383	CbGeAlD
Canagliflozin—SLC5A1—Disease—ATP6V0A4—nephrolithiasis	0.00143	0.00365	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ATP6V0A4—nephrolithiasis	0.00143	0.00365	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00139	0.00356	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00139	0.00356	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GRHPR—nephrolithiasis	0.00137	0.0035	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SLC26A1—nephrolithiasis	0.00135	0.00343	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SLC26A1—nephrolithiasis	0.00135	0.00343	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—APRT—nephrolithiasis	0.00135	0.00343	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—APRT—nephrolithiasis	0.00135	0.00343	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00131	0.00335	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00124	0.00317	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AGXT—nephrolithiasis	0.00122	0.00312	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0012	0.00306	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0012	0.00306	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00114	0.0029	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00114	0.0029	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—APRT—nephrolithiasis	0.00104	0.00265	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SLC26A1—nephrolithiasis	0.00104	0.00265	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—AQP1—nephrolithiasis	0.000959	0.00245	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—AQP1—nephrolithiasis	0.000959	0.00245	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00091	0.00232	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00091	0.00232	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CHRM3—nephrolithiasis	0.000867	0.00221	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CHRM3—nephrolithiasis	0.000867	0.00221	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000862	0.0022	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000862	0.0022	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000859	0.00219	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.000846	0.00216	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.000846	0.00216	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000801	0.00204	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000801	0.00204	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000754	0.00192	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000749	0.00191	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000749	0.00191	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—AQP1—nephrolithiasis	0.00074	0.00189	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000714	0.00182	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000714	0.00182	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CHRM3—nephrolithiasis	0.00067	0.00171	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000667	0.0017	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000656	0.00167	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000656	0.00167	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000636	0.00162	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00061	0.00156	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00061	0.00156	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000585	0.00149	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000571	0.00146	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000535	0.00136	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000535	0.00136	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.000507	0.00129	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000462	0.00118	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000462	0.00118	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000452	0.00115	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000443	0.00113	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—DGKH—nephrolithiasis	0.000443	0.00113	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00043	0.0011	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00043	0.0011	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000405	0.00103	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000405	0.00103	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000385	0.000981	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000385	0.000981	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000383	0.000977	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000383	0.000977	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000377	0.000961	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000377	0.000961	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000336	0.000856	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000336	0.000856	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000306	0.000781	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000274	0.000699	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000268	0.000685	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GRHPR—nephrolithiasis	0.000266	0.000678	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.000248	0.000632	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AGXT—nephrolithiasis	0.000237	0.000604	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000233	0.000594	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000207	0.000529	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—APRT—nephrolithiasis	0.000201	0.000514	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000201	0.000514	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000176	0.00045	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000176	0.00045	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—AQP1—nephrolithiasis	0.000143	0.000366	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000143	0.000366	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CHRM3—nephrolithiasis	0.00013	0.000331	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000128	0.000326	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000126	0.000321	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000114	0.00029	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000109	0.000277	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000109	0.000277	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—AQP1—nephrolithiasis	7.74e-05	0.000198	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7e-05	0.000179	CbGpPWpGaD
